Role of progesterone on the regulation of vascular muscle cells proliferation, migration and apoptosis

Steroids

Volumn 75, Issue 4-5, 2010, Pages 355-361

  Cutini, Pablo H ^a,b   Massheimer, Virginia L ^a,b  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Apoptosis; Genomic; Progesterone; Proliferation; Signal transduction; Steroid

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHELERYTHRINE; HYDROGEN PEROXIDE; INDOMETACIN; MIDOSTAURIN; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE 14; PROGESTERONE; PROGESTERONE RECEPTOR; PROSTAGLANDIN SYNTHASE; THYMIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; APOPTOSIS; ARTICLE; CELL ASSAY; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DNA FRAGMENTATION; DNA SYNTHESIS; ENDOTHELIUM CELL; FEMALE; HORMONE ACTION; MUSCLE CELL; NONHUMAN; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; BENZOPHENANTHRIDINES; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; DNA; ENDOTHELIAL CELLS; ESTRADIOL; FEMALE; FLAVONOIDS; INDOMETHACIN; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; PROGESTERONE; RATS; RATS, WISTAR; TIME FACTORS;

RATTUS;

EID: 77949265518     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.01.017     Document Type: Article

References (44)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1991s. Nature 362 (1993) 801-809
2. Pauly R.R., Passaniti A., Bilato C., Monticone R., Cheng L., Papadopoulus N., et al. Migration of cultured vascular smooth cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 75 (1994) 41-54
3. Granville D.J., Carthy C.M., Hunt D.W., and McManus B.M. Apoptosis: molecular aspects of cell death and disease. Lab Invest 78 (1998) 893-913
4. Bochatan-Piallat M.L., Gabbiani F., Redard M., Desmouliere A., and Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 146 (1995) 1059-1064
5. Ouyang P., Michos E.D., and Karas R.H. Hormone replacement therapy and the cardiovascular system. J Am Coll Cardiol 47 (2006) 1741-1753
6. Orshal J.M., and Khalil R.A. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286 (2004) R233-R249
7. Vazquez F., Rodriguez-Manzaneque J.C., Lidon J.P., Edwards D.P., O'Malley B.W., and Iruela-Arispe M.L. Progesterone regulates proliferation of endothelial cells. J Biol Chem 274 (1999) 2185-2192
8. Nakamura Y., Suzuki T., Inoue T., Tazawa C., Ono K., Moriya T., et al. Progesterone receptor subtypes in vascular smooth muscle cells of human aorta. Endocr J 52 (2005) 245-252
9. Falkenstein E., Meyer C., Eisen C., Scriba P.C., and Wehling M. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun 229 (1996) 86-89
10. Lösel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C., Rossol-Haseroth K., et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 83 (2003) 965-1016
11. Fu X.D., and Simoncini T. Non genomic sex steroid actions in the vascular system. Semin Reprod Med 25 (2007) 178-186
12. Sellés J., Polini N., Alvarez C., and Massheimer V. Progesterone and 17 beta-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation. Life Sci 69 (2001) 815-827
13. Sellés J., Polini N., Alvarez C., and Massheimer V. Non genomic action of progesterone in rat aorta: role of nitric oxide and prostaglandins. Cell Signal 14 (2002) 431-436
14. Mendiberri J., Rauschemberger M.B., Sellés J., and Massheimer V. Involvement of phosphoinositide-3-kinase and phospholipase C transduction systems in the non-genomic action of progesterone in vascular tissue. Int J Biochem Cell Biol 38 (2006) 288-296
15. Cutini P., Sellés J., and Massheimer V. Cross-talk between rapid and long term effects of progesterone on vascular tissue. J Steroid Biochem Mol Biol 115 (2009) 36-43
16. Dulbecco R., and Freeman G. Plaque production by the Polyoma virus. Virology 8 (1959) 396-397
17. Yeh Y.C., Hwang G.Y., Liu I.P., and Yang V.C. Identification and expression of scavenger receptor SR-BI in endothelial cells and smooth muscle cells of rat aorta in vitro and in vivo. Atherosclerosis 161 (2002) 95-103
18. Rauschemberger M.B., Sellés J., and Massheimer V. The direct action of estrone on vascular tissue involves genomic and non-genomic actions. Life Sci 82 (2008) 115-123
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
20. Kyaw M., Yoshizumi M., Tsuchiya K., Kirima K., Suzaki Y., Abe S., et al. Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). Biochem Pharmacol 64 (2002) 1521-1531
21. Soares R., Guerreiro S., and Botelho M. Elucidating progesterone effects in breast cancer: cross talk with PDGF signaling pathway in smooth muscle cell. J Cell Biochem 100 (2007) 174-183
22. Bürk R.R. A factor from a transformed cell line that affects cell migration. Proc Natl Acad Sci USA 70 (1973) 369-372
23. Pedram A., Razandi M., Aitkenhead M., Hughes C.C., and Levin E.R. Integration of the non-genomic and genomic actions of estrogen. J Biol Chem 277 (2002) 50768-50775
24. Hurst-Kennedy J., Boyan B.D., and Schwartz Z. Lysophosphatidic acid signaling promotes proliferation, differentiation, and cell survival in rat growth plate chondrocytes. Biochim Biophys Acta 1793 (2009) 836-846
25. Artwohl M., Lindenmair A., Roden M., Waldhäusl W.K., Freudenthaler A., Klosner G., et al. Fatty acids induce apoptosis in human smooth muscle cells depending on chain length, saturation, and duration of exposure. Atherosclerosis 202 (2009) 351-362
26. Yusuf S., Wittes J., Probstfield J., and Tyroler H. Comparing groups: the multiple testing problem. In: Lang T., and Secic M. (Eds). How to report statistics in medicine (1997), American College of Physicians;, Philadelphia 81-92
27. Karas R.H., van Eickels M., Lidon J.P., Roddy S., Kwoun M., Aronovitz M., et al. A complex role for the progesterone receptor in the response to vascular injury. J Clin Invest 108 (2001) 611-618
28. Morey A.K., Pedram A., Razandi M., Prins B.A., Hu R.M., Biesiada E., et al. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 138 (1997) 3330-3339
29. White M.M., Zamudio S., Stevens T., Tyer R., Lindenfeld J., Leslie K., et al. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev 16 (1995) 739-751
30. Scharfman H.E., Mercurio T.C., Goodman J.H., Wilson M.A., and MacLusky N.J. Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brain-derived neurotrophic factor. J Neurosci 23 (2003) 11641-11652
31. Haynes M.P., Li L., Russell K.S., and Bender J.R. Rapid vascular cell responses to estrogen and membrane receptors. Vascul Pharmacol 38 (2002) 99-108
32. Liou Y.M., and Morgan K.G. Redistribution of protein kinase C isoforms in association with vascular hypertrophy of rat aorta. Am J Physiol 267 (1994) C980-C989
33. Turner N.A., Ball S.G., and Balmforth A.J. The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT(1A) receptor internalization. Cell Signal 13 (2001) 269-277
34. Pomerantz K.B., and Hajjar D.P. Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism. Arterioscler Thromb Vasc Biol 9 (1989) 413-429
35. Tzeng H.P., Yang R.S., Ueng T.H., and Liu S.H. Upregulation of cyclooxygenase-2 by motorcycle exhaust particulate-induced reactive oxygen species enhances rat vascular smooth muscle proliferation. Chem Res Toxicol 20 (2007) 1170-1176
36. Cucina A., Borelli V., Randone B., Coluccia P., Sapienza P., and Cavallaro A. Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells. J Surg Res 109 (2003) 16-23
37. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
38. Sarrel P.M. How progestins compromise the cardioprotective effects of estrogens. Menopause 2 (1995) 187-190
39. Wassman K., Wassman S., and Nickening G. Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ Res 97 (2005) 1046-1054
40. Rosano G.M., Webb C.M., Chierchia S., Morgani G.L., Gabraele M., Sarrel P.M., et al. Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women. J Am Coll Cardiol 36 (2000) 2154-2159
41. Simoncini T., Mannella P., Fornari L., Caruso A., Willis M., Garibaldi S., et al. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 145 (2004) 5745-5756
42. Askari B., Carroll M.A., Cappareli M., Kramer F., Gerrity R.G., and Bornfeldt K.E. Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-1 through a phospholipase D-dependent pathway in arterial smooth muscle cells. J Biol Chem 277 (2002) 36338-36344
43. Slomp J., Gittenberger-de Groot A.C., Glukhova M.A., Conny van Munsteren J., Kockx M.M., Schwartz S.M., et al. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol 17 (1997) 1003-1009
44. Kockx M.M., and Herman A.G. Apoptosis in atherosclerosis: beneficial or detrimental?. Cardiovasc Res 45 (2000) 736-746